All of these individuals had partaken in medical research at some stage in their careers, and about half of them were actively involved in research regarding treating cancer patients at the time of my treatment. One of them sat on the board of a private pharmaceuticals company, another was an adviser to a government agency. If you look across the world there must be hundreds of thousands, if not millions of people like them.
They are the people I am being asked to believe are conspiring to keep the truth hidden from me in order to keep their jobs. I believe that every single one of them would gladly quit their profession and retrain tomorrow if their patients could suddenly be cured without their help. Yet this conspiracy theory requires not just one or two bad-apples knowingly letting their patients die, but a huge number, probably the majority, of medical professionals, in medical research, would need to be involved.
Currently, large doses of chemotherapy are required when treating certain forms of cancer, resulting in toxic side effects. The chemicals enter the body and work to destroy or shrink the tumor, but also harm vital organs and drastically affect bodily functions. Now, scientists at the University of Missouri have proven that a new form of prostate cancer treatment that uses radioactive gold nanoparticles, and was developed at MU, is safe to use in dogs. Sandra Axiak-Bechtel, an assistant professor in oncology at the MU College of Veterinary Medicine, says that this is a big step for gold nanoparticle research.
"Proving that gold nanoparticles are safe to use in the treatment of prostate cancer in dogs is a big step toward gaining approval for clinical trials in men," Axiak-Bechtel said. "Dogs develop prostate cancer naturally in a very similar way as humans, so the gold nanoparticle treatment has a great chance to translate well to human patients."
For their treatment, Kattesh Katti, a curators' professor of radiology and physics in the School of Medicine and the College of Arts and Science, and other MU scientists, have found a more efficient way of targeting prostate tumors by using radioactive gold nanoparticles. This new treatment would require doses that are thousands of times smaller than chemotherapy and do not travel through the body inflicting damage to healthy areas.
"We found remarkable results in mice, which showed a significant reduction in tumor volume through single injections of the radioactive gold nanoparticles," said Katti. "These findings have formed a solid foundation, and we hope to translate the utility of this novel nanomedicine therapy to treating human cancer patients."
Read more at: http://phys.org/news/2012-10-gold-nanoparticle-prostate-cancer-treatment.html#jCp
"Proving that gold nanoparticles are safe to use in the treatment of prostate cancer in dogs is a big step toward gaining approval for clinical trials in men," Axiak-Bechtel said. "Dogs develop prostate cancer naturally in a very similar way as humans, so the gold nanoparticle treatment has a great chance to translate well to human patients."
For their treatment, Kattesh Katti, a curators' professor of radiology and physics in the School of Medicine and the College of Arts and Science, and other MU scientists, have found a more efficient way of targeting prostate tumors by using radioactive gold nanoparticles. This new treatment would require doses that are thousands of times smaller than chemotherapy and do not travel through the body inflicting damage to healthy areas.
"We found remarkable results in mice, which showed a significant reduction in tumor volume through single injections of the radioactive gold nanoparticles," said Katti. "These findings have formed a solid foundation, and we hope to translate the utility of this novel nanomedicine therapy to treating human cancer patients."
Read more at: http://phys.org/news/2012-10-gold-nanoparticle-prostate-cancer-treatment.html#jCp
No comments:
Post a Comment